Use of intravenous etomidate to control acute psychosis induced by the hypercortisolaemia in severe paediatric Cushing's disease

Hormone Research in Paediatrics

Volumn 75, Issue 6, 2011, Pages 441-446

  Chan, L F ^a   Vaidya, M ^a   Westphal, B ^a   Allgrove, J ^a   Martin, L ^a   Afshar, F ^a   Hindmarsh, P C ^a   Savage, M O ^a   Grossman, A B ^a   Storr, H L ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Childhood; Cushing's disease; Etomidate; Psychosis

Indexed keywords

ETOMIDATE; HYDROCORTISONE; KETOCONAZOLE;

ACUTE PSYCHOSIS; ADOLESCENT; ADRENALECTOMY; ARTICLE; AUTOMUTILATION; CASE REPORT; CUSHING SYNDROME; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; EMERGENCY CARE; FEMALE; HUMAN; HYPERCORTISOLISM; INTENSIVE CARE; INTENSIVE CARE UNIT; LOW DRUG DOSE; MENTAL HEALTH; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSSPHENOIDAL SURGERY;

ADOLESCENT; ANESTHETICS, INTRAVENOUS; CUSHING SYNDROME; ETOMIDATE; FEMALE; HUMANS; PITUITARY ACTH HYPERSECRETION; PSYCHOTIC DISORDERS; SELF-INJURIOUS BEHAVIOR;

EID: 79957942998     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000324419     Document Type: Article

References (50)

1. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP: Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994; 331: 629-636.
2. Storr HL, Chan LF, Grossman AB, Savage MO: Paediatric Cushing's syndrome: Epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 2007; 18: 167-174. (Pubitemid 46629027)
3. Nieman LK, Biller BMK, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing's syndrome: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93: 1526-1540. (Pubitemid 351656485)
4. Storr HL, Plowman PN, Carroll PV, Francois I, Krassas GE, Afshar F, Besser GM, Grossman AB, Savage MO: Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: An effective secondline treatment. J Clin Endocrinol Metab 2003; 88: 34-37. (Pubitemid 36115139)
5. Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, Savage MO: Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. Eur J Endocrinol 2007; 156: 477-482. (Pubitemid 46672649)
6. Greening JE, Brain CE, Perry LA, Mushtaq I, Sales Marques J, Grossman AB, Savage MO: Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease. Horm Res 2005; 64: 140-143. (Pubitemid 41507296)
7. Rothermel LK: Newer pharmacologic agents for procedural sedation of children in the emergency department -etomidate and propofol. Curr Opin Pediatr 2003; 15: 200-203. (Pubitemid 36337833)
8. Butovas S, Rudolph U, Jurd R, Schwarz C, Antkowiak B: Activity patterns in the prefrontal cortex and hippocampus during and after awakening from etomidate anesthesia. Anesthesiology 2010; 113: 48-57.
9. Nieman LK: Medical therapy of Cushing's disease. Pituitary 2002; 5: 77-82. (Pubitemid 36336012)
10. Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM: Psychiatric manifestations of Cushing's syndrome: Response to lowering of plasma cortisol. Q J Med 1979; 48: 465-472. (Pubitemid 10200362)
11. Sonino N, Fava GA: Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 2001; 15: 361-373.
12. Sonino N, Bonnini S, Fallo F, Boscaro M, Fava GA: Personality characteristics and quality of life in patients treated for Cushing's syndrome. Clin Endocrinol (Oxf) 2006; 64: 314-318.
13. Hirsch D, Orr G, Kantarovich V, Hermesh H, Stern E, Blum I: Cushing's syndrome presenting as a schizophrenia-like psychotic state. Isr J Psychiatry Relat Sci 2000; 37: 46-50.
14. Tran M, Elias AN: Severe myopathy and psychosis in a patient with Cushing's disease macroadenoma. Clin Neurol Neurosurg 2003; 106: 1-4. (Pubitemid 37468492)
15. Marshall WA, Tanner JM: Variations in pattern of pubertal changes in girls. Arch Dis Child 1969; 44: 291-303.
16. Krakoff J, Koch CA, Calis KA, Alexander RH, Nieman LK: Use of a parenteral propylene glycol-containing etomidate preparation for the long-term management of ectopic Cushing's syndrome. J Clin Endocrinol Metab 2001; 86: 4104-4108. (Pubitemid 32848520)
17. Frank R, Doerr HG: Mania in a girl with Cushing's disease. J Am Acad Child Adolesc Psychiatry 1989; 28: 610-611. (Pubitemid 19196302)
18. Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE: Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom Med 2001; 63: 985-993. (Pubitemid 33101385)
19. Sapolsky RM: The possibility of neurotoxicity in the hippocampus in major depression: A primer on neuron death. Biol Psychiatry 2000; 48: 755-765.
20. Wolkowitz OM, Burke H, Epel ES, Reus VI: Glucocorticoids. Ann NY Acad Sci 2009; 1179: 19-40.
21. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK: Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 2006; 91: 447-453. (Pubitemid 43236908)
22. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M: Diagnosis and complications of Cushing's syndrome: A consensus statement. J Clin Endocrinol Metab 2003; 88: 5593-5602. (Pubitemid 38033020)
23. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP: The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997; 82: 912-919. (Pubitemid 27106611)
24. Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L, Lacroix A: Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002; 87: 1949-1954. (Pubitemid 34521472)
25. Forget H, Lacroix A, Cohen H: Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 2002; 27: 367-383. (Pubitemid 34121979)
26. Merke DP, Giedd JN, Keil MF, Mehlinger SL, Wiggs EA, Holzer S, Rawson E, Vaituzis AC, Stratakis CA, Chrousos GP: Children experience cognitive decline despite reversal of brain atrophy one year after resolution of Cushing syndrome. J Clin Endocrinol Metab 2005; 90: 2531-2536. (Pubitemid 40686287)
27. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, Pereira AM, Romijn JA: Subtle cognitive impairments in patients with long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95: 2699-2714.
28. Tiemensma J, Biermasz NR, Middelkoop HA, van der Mast RC, Romijn JA, Pereira AM: Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95:E129-E141.
29. Keil MF, Merke DP, Gandhi R, Wiggs EA, Obunse K, Stratakis CA: Quality of life in children and adolescents one year after cure of Cushing syndrome: A prospective study. Clin Endocrinol (Oxf) 2009; 71: 326-333.
30. Ledingham IM, Watt I: Influence of sedation on mortality in critically ill multiple trauma patients. Lancet 1983; 1: 1270. (Pubitemid 13100048)
31. Watt I, Ledingham IM: Mortality amongst multiple trauma patients admitted to an intensive therapy unit. Anaesthesia 1984; 39: 973-981. (Pubitemid 15076641)
32. Klausen NO, Moelgaard J, Ferguson AH, Jensen JK, Larsen C, Paaby P: Negative Synacthen test during etomidate infusion. Lancet 1983; 2: 848. (Pubitemid 13009277)
33. Lambert A, Mitchell R, Frost J, Ratcliffe JG, Robertson WR: Direct in vitro inhibition of adrenal steroidogenesis by etomidate. Lancet 1983; 2: 1085-1086. (Pubitemid 14235383)
34. Allolio B, Dorr H, Stuttmann R, Knorr D, Engelhardt D, Winkelmann W: Effect of a single bolus of etomidate upon eight major corticosteroid hormones and plasma ACTH. Clin Endocrinol (Oxf) 1985; 22: 281-286. (Pubitemid 15127297)
35. Dorr HG, Kuhnle U, Holthausen H, Bidlingmaier F, Knorr D: Etomidate: A selective adrenocortical 11α-hydroxylase inhibitor. Klin Wochenschr 1984; 62: 1011-1013. (Pubitemid 14017346)
36. Johnson TN, Canada TW: Etomidate use for Cushing's syndrome caused by an ectopic adrenocorticotropic hormone-producing tumor. Ann Pharmacother 2007; 41: 350-353. (Pubitemid 46340068)
37. Drake WM, Perry LA, Hinds CJ, Lowe DG, Reznek RH, Besser GM: Emergency and prolonged use of intravenous etomidate to control hypercortisolemia in a patient with Cushing's syndrome and peritonitis. J Clin Endocrinol Metab 1998; 83: 3542-3544. (Pubitemid 28500886)
38. Bilgin YM, van der Wiel HE, Fischer HR, De Herder WW: Treatment of severe psychosis due to ectopic Cushing's syndrome. J Endocrinol Invest 2007; 30: 776-779. (Pubitemid 350238205)
39. Allolio B, Schulte HM, Kaulen D, Reincke M, Jaursch-Hancke C, Winkelmann W: Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's syndrome. Klin Wochenschr 1988; 66: 361-364.
40. Dabbagh A, Sa'adat N, Heidari Z: Etomidate infusion in the critical care setting for suppressing the acute phase of Cushing's syndrome. Anesth Analg 2009; 108: 238-239.
41. Lamberts SW, Bons EG, Bruining HA, de Jong FH: Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells. J Pharmacol Exp Ther 1987; 240: 259-264. (Pubitemid 17235446)
42. Fassnacht M, Hahner S, Beuschlein F, Klink A, Reincke M, Allolio B: New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line. Eur J Clin Invest 2000; 30(suppl 3):76-82. (Pubitemid 32154555)
43. Lambert A, Frost J, Mitchell R, Robertson WR: On the assessment of the in vitro biopotency and site(s) of action of drugs affecting adrenal steroidogenesis. Ann Clin Biochem 1986; 23: 225-229. (Pubitemid 16081560)
44. Vanden Bossche H, Willemsens G, Cools W, Bellens D: Effects of etomidate on steroid biosynthesis in subcellular fractions of bovine adrenals. Biochem Pharmacol 1984; 33: 3861-3868. (Pubitemid 15220879)
45. Wagner RL, White PF, Kan PB, Rosenthal MH, Feldman D: Inhibition of adrenal steroidogenesis by the anesthetic etomidate. N Engl J Med 1984; 310: 1415-1421. (Pubitemid 14101296)
46. Varga I, Racz K, Kiss R, Futo L, Toth M, Sergev O, Glaz E: Direct inhibitory effect of etomidate on corticosteroid secretion in human pathologic adrenocortical cells. Steroids 1993; 58: 64-68.
47. Weber MM, Lang J, Abedinpour F, Zeilberger K, Adelmann B, Engelhardt D: Different inhibitory effect of etomidate and ketoconazole on the human adrenal steroid biosynthesis. Clin Investig 1993; 71: 933-938. (Pubitemid 23327482)
48. Allolio B, Stuttmann R, Fischer H, Leonhard W, Winkelmann W: Long-term etomidate and adrenocortical suppression. Lancet 1983; 322: 626. (Pubitemid 13051068)
49. Schulte HM, Benker G, Reincke M, Sippell WG, Allolio B: Infusion of low-dose etomidate: Correction of hypercortisolemia in patients with Cushing's syndrome and doseresponse relationship in normal subjects. J Clin Endocrinol Metab 1990; 70: 1426-1430.
50. Gartner R, Albrecht M, Muller OA: Effect of etomidate on hypercortisolism due to ectopic ACTH production. Lancet 1986; 1: 275. (Pubitemid 16132884)